Explore the detailed record of transactions filed by Johan Living, 首席执行官. Insider active across 2 companies, notably Lipigon Pharmaceuticals AB. Cumulatively, 1 filings have been published. Activity tracked since 21 May 2025. The latest transaction was disclosed on 21 May 2025 (Purchase). Regulator: FIN-FSA. The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条
Nikolaj Arrild Sørensen is the Chief Executive Officer of Orexo AB. In this role, he is responsible for the overall management of the company and the implementation of its strategy. Orexo AB is a Swedish company specializing in the development of treatments for addiction disorders. Through his leadership, Nikolaj Arrild Sørensen contributes to the growth and innovation of the company.